Loading...

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:14:57

Zurich based CUTISS is developing a personalized...

BiotechTV - News ·

2025/05/01

Co-Founder & CEO Daniela Marino describes why CUTISS believes denovoSKIN is superior to autografting. She describes how they make it, walks us through the company's on-site GMP facility, and she discusses the clinical experience to date. The therapy is already in a phase 3 study in Europe.

en-us

00:12:20

London based Baseimmune shows BiotechTV the new space...

BiotechTV - News ·

2025/04/29

Co-founder & CEO Joshua Blight talks about Baseimmune's platform, which was inspired by the work that happened during COVID both in the UK and abroad. The company's current focus is on COVID and malaria.

en-us

00:10:51

Creyon Bio today announced a collaboration to help...

BiotechTV - News ·

2025/04/29

Recently named CEO Serge Messerlian, who was previously CEO of Teon Therapeutics and President of Janssen Oncology, describes the platform behind this deal, which came with an upfront payment/investment of $13 million.

en-us

00:12:14

London based Laverock shows BiotechTV the new space...

BiotechTV - News ·

2025/04/29

CEO David Venables describes Laverock's platform that repurposed miRNA to reprogram cells in a highly specific way. It's own lead programs will be in oncology and regenerative medicine.

en-us

00:09:47

The London BioScience Innovation Centre (LBIC) today...

BiotechTV - News ·

2025/04/29

Dr. Rich Ferrie gives BiotechTV a preview of the new facilities and describes how it is aimed for growing companies that have already achieved a series A or B. It has started at 37% occupancy on launch day.

en-us

00:19:04

Talking chromatin regulation at Foghorn Therapeutics...

BiotechTV - News ·

2025/04/25

CEO Adrian Gottschalk describes chromatin regulation at a high level, and walks us through the Lilly partnership targeting SMARCA2, and Foghorn's independent programs targeting CBP, EP300, and ARID1B.

en-us

00:28:48

Epicrispr Biotechnologies' CEO Amber Salzman...

BiotechTV - News ·

2025/04/25

She describes why such an analysis would be beneficial in analyzing clinical benefit for this type of condition - where the patient population is heterogenous in how they are affected by the disease. Plus, a description of Epicrispr's epigenome approach to science, and her personal relationship to facioscapulohumeral muscular dystrophy.

en-us

00:17:55

Lexeo Therapeutics' CEO Nolan Townsend highlights...

BiotechTV - News ·

2025/04/23

He describes the clinical data in FA cardiomyopathy that was announced this month, and explains how the company is preparing to begin a clinical trial for accelerated approval by early 2026. Plus, how we should expect more ACM data in 2025.

en-us

00:23:32

Metsera's CEO Whit Bernard on the obesity space,...

BiotechTV - News ·

2025/04/23

He describes how Metsera, which had its IPO two months ago, is aiming to develop a differentiated GLP-1 vs currently marketed products by having a lower dose and longer half-life. We discuss all the hot button issues in the obesity space today.

en-us

00:17:24

On its 10-year anniversary, Arcus Biosciences is...

BiotechTV - News ·

2025/04/17

He describes the market potential of the company's HIF-2⍺, a target that has already been de-risked by a large pharma, why he believes being Fc silent will allow Arcus to succeed in TIGIT where others have failed, and a CD73 program that is enrolling very quickly in pancreatic cancer.

en-us

00:12:52

As federal funding for cancer research has been...

BiotechTV - News ·

2025/04/16

CSO John Connolly describes how recent new hires and a willingness to lead will expand PICI's already broad reach in cancer research circles. Plus, his take on what regulatory reforms could help U.S. competitiveness, and areas of research that excite him today.

en-us

00:10:38

Siren Biotechnology is using an online platform to...

BiotechTV - News ·

2025/04/16

Founder and CEO Nicole Paulk describes the process, which allows the public to invest as little as $100, and why she views the investors that come with it as an asset for her company.

en-us

00:16:07

Theravance Biopharma has a key pivotal trial readout...

BiotechTV - News ·

2025/04/15

CEO Rick Winningham describes the science behind ampreloxetine, and the rationale for developing it for patients with multiple system atrophy. A commercial stage company that already receives income from two therapies (YUPELRI and TRELEGY), Theravance Biopharma's future direction and focus will be determined by the outcome of this key trial.

en-us

00:17:07

Marea Therapeutics today announced acceptance of a...

BiotechTV - News ·

2025/04/15

CEO Josh Lehrer and CSO Ethan Weiss describe the biology of the target and highlight the topline data, which was first announced at #JPM25. Plus, details on a new program targeting acromegaly.

en-us

00:19:09

After switching to a new GalNAc-LNP delivery vehicle...

BiotechTV - News ·

2025/04/14

Co-Founder & CEO Sek Kathiresan walks us through the data, which so far has showed a clean safety profile and an impressive ability to lower LDL by over 50% in patients with a genetic form of hypercholesterolemia.

en-us

00:11:41

Mount Sinai has embraced AI as a drug discovery tool...

BiotechTV - News ·

2025/04/10

Dr. Schlessinger descrbies how the new center is meant to speed up drug discovery work and enable Mount Sinai researchers to develop molecules that are more dynamic and with a higher success rate. It might also enable them to take drug development further than they traditionally have before.

en-us

00:14:30

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/10

They discusses takeaways from the conference, and comment on Beam, Korro, Wave, Intellia, Prime, Janux, Alto Nuero, Rapport, and YmAbs.

en-us

00:07:37

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/10

CFO David Nassif describes the unmet need that still exists today in HAE, and updates us on programs in both the acute and prophylactic settings.

en-us

00:13:47

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/10

He describes where this fits into the ROS1 space, and the data that has been derived for the filing. Plus, mIDH1, drug-drug-conjugates, and his take on the current environment in biotech.

en-us

00:15:27

Jones Healthcare & Technology Innovation Conference:...

BiotechTV - News ·

2025/04/09

He describes the 48 week data for the exon 53 DMD program, and discusses the company's plan to seek accelerated approval. Plus, guidance on when to expect clinical updates on other programs.

en-us

486 results

Similar Podcasts

Astounding Stories 10

Ray Cummings

Das Wissen | SWR

SWR

Rabbit Hole of Research

Jotham Austin, II PhD, Nick Elizalde,...

תל אביב 360 – ערוץ הפודקסטים של אוניברסיטת תל אביב

Tel Aviv University

2026 Nuestro Oxígeno 10- Octubre

Nuestro Oxígeno